These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29603084)

  • 1. Multi-faceted Characterization of Wet-milled Griseofulvin Nanosuspensions for Elucidation of Aggregation State and Stabilization Mechanisms.
    Li M; Alvarez P; Orbe P; Bilgili E
    AAPS PharmSciTech; 2018 May; 19(4):1789-1801. PubMed ID: 29603084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the combination of cellulosic polymers and anionic surfactants a good strategy for ensuring physical stability of BCS Class II drug nanosuspensions?
    Bilgili E; Li M; Afolabi A
    Pharm Dev Technol; 2016; 21(4):499-510. PubMed ID: 25774989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redispersible fast dissolving nanocomposite microparticles of poorly water-soluble drugs.
    Bhakay A; Azad M; Bilgili E; Dave R
    Int J Pharm; 2014 Jan; 461(1-2):367-79. PubMed ID: 24333905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combined microhydrodynamics-polymer adsorption analysis for elucidation of the roles of stabilizers in wet stirred media milling.
    Bilgili E; Afolabi A
    Int J Pharm; 2012 Dec; 439(1-2):193-206. PubMed ID: 23018114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced recovery and dissolution of griseofulvin nanoparticles from surfactant-free nanocomposite microparticles incorporating wet-milled swellable dispersants.
    Bhakay A; Azad M; Vizzotti E; Dave RN; Bilgili E
    Drug Dev Ind Pharm; 2014 Nov; 40(11):1509-22. PubMed ID: 23981202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous production of drug nanoparticle suspensions via wet stirred media milling: a fresh look at the Rehbinder effect.
    Monteiro A; Afolabi A; Bilgili E
    Drug Dev Ind Pharm; 2013 Feb; 39(2):266-83. PubMed ID: 22503097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous quantification of polymeric and surface active stabilizers of nanosuspensions by using near-infrared spectroscopy.
    Cerdeira AM; Werner IA; Mazzotti M; Gander B
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1360-70. PubMed ID: 22296216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid nanocrystal-amorphous solid dispersions (HyNASDs) as alternative to ASDs for enhanced release of BCS Class II drugs.
    Rahman M; Arevalo F; Coelho A; Bilgili E
    Eur J Pharm Biopharm; 2019 Dec; 145():12-26. PubMed ID: 31622652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spray drying of drug-swellable dispersant suspensions for preparation of fast-dissolving, high drug-loaded, surfactant-free nanocomposites.
    Azad M; Arteaga C; Abdelmalek B; Davé R; Bilgili E
    Drug Dev Ind Pharm; 2015; 41(10):1617-31. PubMed ID: 25347144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on the stabilization mechanisms of wet-milled cepharanthine nanosuspensions using systematical characterization.
    Fu T; Gu X; Liu Q; Peng X; Yang J
    Drug Dev Ind Pharm; 2020 Feb; 46(2):200-208. PubMed ID: 31933388
    [No Abstract]   [Full Text] [Related]  

  • 11. Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability.
    Cerdeira AM; Mazzotti M; Gander B
    Int J Pharm; 2010 Aug; 396(1-2):210-8. PubMed ID: 20600732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of Rheology and Polymer Adsorption Onto Drug Nanoparticles in Pharmaceutical Suspensions Produced by Nanomilling.
    Negrini R; Aleandri S; Kuentz M
    J Pharm Sci; 2017 Nov; 106(11):3395-3401. PubMed ID: 28732711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and drying of miconazole and itraconazole nanosuspensions.
    Cerdeira AM; Mazzotti M; Gander B
    Int J Pharm; 2013 Feb; 443(1-2):209-20. PubMed ID: 23291552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced physical stabilization of fenofibrate nanosuspensions via wet co-milling with a superdisintegrant and an adsorbing polymer.
    Azad M; Afolabi A; Bhakay A; Leonardi J; Davé R; Bilgili E
    Eur J Pharm Biopharm; 2015 Aug; 94():372-85. PubMed ID: 26079832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of arginine hydrochloride and hydroxypropyl cellulose as stabilizers on the physical stability of high drug loading nanosuspensions of a poorly soluble compound.
    Ain-Ai A; Gupta PK
    Int J Pharm; 2008 Mar; 351(1-2):282-8. PubMed ID: 18036751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications.
    Sievens-Figueroa L; Bhakay A; Jerez-Rozo JI; Pandya N; Romañach RJ; Michniak-Kohn B; Iqbal Z; Bilgili E; Davé RN
    Int J Pharm; 2012 Feb; 423(2):496-508. PubMed ID: 22178619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of process parameters on the breakage kinetics of poorly water-soluble drugs during wet stirred media milling: a microhydrodynamic view.
    Afolabi A; Akinlabi O; Bilgili E
    Eur J Pharm Sci; 2014 Jan; 51():75-86. PubMed ID: 24036164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A microhydrodynamic rationale for selection of bead size in preparation of drug nanosuspensions via wet stirred media milling.
    Li M; Alvarez P; Bilgili E
    Int J Pharm; 2017 May; 524(1-2):178-192. PubMed ID: 28380391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quiescent and Agitated Redispersion as a Tool for Evaluating Dispersant Effectiveness in Dissolution Enhancement of Drug-Laden Nanocomposites.
    Bhakay A; Davé RN; Bilgili E
    AAPS PharmSciTech; 2018 Jan; 19(1):436-447. PubMed ID: 28770528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
    Patel PJ; Gajera BY; Dave RH
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.